Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids

Neurochemical Research

Volumn 34, Issue 10, 2009, Pages 1738-1747

  Habjan, Suzanne ^a   Vandenberg, Robert J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Flufenamic acid; Glutamate transporters; Glycine transporters; Mefenamic acid; Niflumic acid

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER; FLUFENAMIC ACID; GLUTAMATE TRANSPORTER; GLYCINE TRANSPORTER; MEFENAMIC ACID; NIFLUMIC ACID;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; MOLECULAR BIOLOGY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VOLTAGE CLAMP; XENOPUS LAEVIS;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUFENAMIC ACID; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; MEFENAMIC ACID; MEMBRANE POTENTIALS; NIFLUMIC ACID; XENOPUS LAEVIS;

XENOPUS LAEVIS;

EID: 69049087651     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-9983-y     Document Type: Article

References (44)

1. J Lerma R Martin del Rio 1992 Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation Mol Pharmacol 41 217 222
2. A receptors by the non-steroidal anti-inflammatory agent, mefenamic acid Eur J Neurosci 11 2897 2905 10.1046/j.1460-9568.1999.00709.x
3. A receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug Mol Pharmacol 64 753 763 10.1124/mol.64.3.753
4. A receptors expressed in Xenopus oocytes J Pharmacol Exp Ther 268 806 817
5. H Gogelein D Dahlem HC Englert HJ Lang 1990 Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas FEBS Lett 268 79 82 10.1016/0014-5793(90)80977-Q
6. RC Hogg Q Wang WA Large 1994 Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein Br J Pharmacol 112 977 984
7. + channel, by meclofenamic acid Eur J Pharmacol 378 349 356 10.1016/S0014-2999(99)00485-9
8. A Liantonio A Picollo E Babini G Carbonara G Fracchiolla F Loiodice V Tortorella M Pusch DC Camerino 2006 Activation and inhibition of kidney CLC-K chloride channels by fenamates Mol Pharmacol 69 165 173
9. AP Malykhina F Shoeb HI Akbarali 2002 Fenamate-induced enhancement of heterologously expressed HERG currents in Xenopus oocytes Eur J Pharmacol 452 269 277 10.1016/S0014-2999(02)02330-0
10. EG Harks AD de Roos PH Peters LH de Haan A Brouwer DL Ypey EJ van Zoelen AP Theuvenet 2001 Fenamates: a novel class of reversible gap junction blockers J Pharmacol Exp Ther 298 1033 1041
11. MV Poulsen RJ Vandenberg 2001 Niflumic acid modulates uncoupled substrate-gated conductances in the human glutamate transporter EAAT4 J Physiol 534 159 167 10.1111/j.1469-7793.2001.00159.x
12. WA Fairman MS Sonders GH Murdoch SG Amara 1998 Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4 Nat Neurosci 1 105 113 10.1038/355
13. N Zerangue JL Arriza SG Amara MP Kavanaugh 1995 Differential modulation of human glutamate transporter subtypes by arachidonic acid J Biol Chem 270 6433 6435 10.1074/jbc.270.12.6433
14. B Bannwarth P Netter J Pourel RJ Royer A Gaucher 1989 Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid Biomed Pharmacother 43 121 126 10.1016/0753-3322(89)90140-6
15. PL McGeer EG McGeer 1996 Anti-inflammatory drugs in the fight against Alzheimer's disease Ann N Y Acad Sci 777 213 220 10.1111/j.1749-6632.1996. tb34421.x
16. L Gasparini E Ongini G Wenk 2004 Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action J Neurochem 91 521 536 10.1111/j.1471-4159.2004.02743.x
17. CA Szekely JE Thorne PP Zandi M Ek E Messias JC Breitner SN Goodman 2004 Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review Neuroepidemiology 23 159 169 10.1159/000078501
18. Y Joo HS Kim RS Woo CH Park KY Shin JP Lee KA Chang S Kim YH Suh 2006 Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models Mol Pharmacol 69 76 84
19. Q Chen JW Olney PD Lukasiewicz T Almli C Romano 1998 Fenamates protect neurons against ischemic and excitotoxic injury in chick embryo retina Neurosci Lett 242 163 166 10.1016/S0304-3940(98)00081-0
20. SC Smolinske AH Hall SA Vandenberg DG Spoerke PV McBride 1990 Toxic effects of nonsteroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships Drug Saf 5 252 274 10.2165/00002018-199005040-00003
21. PR Dodd HL Scott RI Westphalen 1994 Excitotoxic mechanisms in the pathogenesis of dementia Neurochem Int 25 203 219 10.1016/0197-0186(94)90064-7
22. S Li M Mallory M Alford S Tanaka E Masliah 1997 Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression J Neuropathol Exp Neurol 56 901 911 10.1097/00005072-199708000-00008
23. HL Scott DV Pow AE Tannenberg PR Dodd 2002 Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease J Neurosci 22 RC206
24. RJ Pearlman KR Aubrey RJ Vandenberg 2003 Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a J Neurochem 84 592 601 10.1046/j.1471-4159.2003.01549.x
25. - channels in Xenopus oocytes Mol Pharmacol 37 720 724
26. AD Mitrovic SG Amara GA Johnston RJ Vandenberg 1998 Identification of functional domains of the human glutamate transporters EAAT1 and EAAT2 J Biol Chem 273 14698 14706 10.1074/jbc.273.24.14698
27. KR Aubrey AD Mitrovic RJ Vandenberg 2000 Molecular basis for proton regulation of glycine transport by glycine transporter subtype 1b Mol Pharmacol 58 129 135
28. MJ Gallagher LH Burgess KR Brunden 1999 Characterization of multiple forms of the human glycine transporter type-2 Brain Res Mol Brain Res 70 101 115 10.1016/S0169-328X(99)00135-7
29. 2+ inhibits glycine transport by glycine transporter subtype 1b J Biol Chem 279 22983 22991 10.1074/jbc.M312484200
30. RJ Vandenberg AD Mitrovic M Chebib VJ Balcar GA Johnston 1997 Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2 Mol Pharmacol 51 809 815
31. RJ Vandenberg AD Mitrovic GA Johnston 1998 Molecular basis for differential inhibition of glutamate transporter subtypes by zinc ions Mol Pharmacol 54 189 196
32. AS Kalgutkar AB Marnett BC Crews RP Remmel LJ Marnett 2000 Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors J Med Chem 43 2860 2870 10.1021/jm000004e
33. RJ Vandenberg P Ju KR Aubrey RM Ryan AD Mitrovic 2004 Allosteric modulation of neurotransmitter transporters at excitatory synapses Eur J Pharm Sci 23 1 11 10.1016/j.ejps.2004.05.006
34. 2+ inhibits the anion conductance of the glutamate transporter EAAT4 J Biol Chem 276 26071 26076 10.1074/jbc.M011318200
35. RP Seal Y Shigeri S Eliasof BH Leighton SG Amara 2001 Sulfhydryl modification of V449C in the glutamate transporter EAAT1 abolishes substrate transport but not the substrate-gated anion conductance Proc Natl Acad Sci USA 98 15324 15329 10.1073/pnas.011400198
36. DK Bhattacharyya M Lecomte CJ Rieke M Garavito WL Smith 1996 Involvement of arginine 120, glutamate 524, tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1 J Biol Chem 271 2179 2184 10.1074/jbc.271.33.20175
37. GM Greig DA Francis JP Falgueyret M Ouellet MD Percival P Roy C Bayly JA Mancini GP O'Neill 1997 The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs Mol Pharmacol 52 829 838
38. JA Mancini D Riendeau JP Falgueyret PJ Vickers GP O'Neill 1995 Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety J Biol Chem 270 29372 29377 10.1074/jbc.270.49.29372
39. RA Copeland JM Williams J Giannaras S Nurnberg M Covington D Pinto S Pick JM Trzaskos 1994 Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase Proc Natl Acad Sci USA 91 11202 11206 10.1073/pnas.91.23.11202
40. WL Smith DL DeWitt 1995 Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs Semin Nephrol 15 179 194
41. R Pouplana C Perez J Sanchez JJ Lozano P Puig-Parellada 1999 The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates J Comput Aided Mol Des 13 297 313 10.1023/A:1008094616324
42. LH Rome WE Lands 1975 Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs Proc Natl Acad Sci USA 72 4863 4865 10.1073/pnas.72.12.4863
43. KM Cullen Z Kocsi J Stone 2005 Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex J Cereb Blood Flow Metab 25 1656 1667 10.1038/sj.jcbfm.9600155
44. DB Drachman K Frank M Dykes-Hoberg P Teismann G Almer S Przedborski JD Rothstein 2002 Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS Ann Neurol 52 771 778 10.1002/ana.10374